2021-01-20 16:29:33 INBK First Internet Bancorp
01/20/21 01/2016:29 01/20/2116:29 | First Internet Bancorp reports Q4 EPS $1.12, consensus 85cReports Q4 revenue $31.5M, consensus $19.56M. Net interest margin and fully-taxable equivalent net interest margin increased 25 and 24 basis points, respectively, from the third quarter, driven by a 22 bps decrease in the cost of interest-bearing deposits. |
|
---|---|---|
|
Hot Stocks
|
CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ »
17:41 02/28/21 02/2817:41 02/28/2117:41
JNJ
Johnson & Johnson
Johnson & Johnson… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
BridgeBio, affiliate Origin Biosciences announce FDA approval of NULIBRY »
16:14 02/28/21 02/2816:14 02/28/2116:14
BBIO
BridgeBio
BridgeBio Pharma and… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Regeneron announces Phase 2 data evaluating antibody cocktail REGN1908-1909 »
16:09 02/28/21 02/2816:09 02/28/2116:09
REGN
Regeneron
Regeneron Pharmaceuticals… Story temporarily locked. ShowHide Related Items >><<
|
Downgrade
|
Harvey Norman downgraded to Neutral from Buy at Goldman Sachs »
10:49 02/28/21 02/2810:49 02/28/2110:49
HNORY
Harvey Norman
Goldman Sachs analyst… Goldman Sachs analyst Andrew McLennan downgraded Harvey Norman to Neutral from Buy with a price target of A$5.10. The analyst acknowledges that Harvey Norman delivered a "very strong" result in the first half of 2021. While conditions were still patchy and unpredictable in parts due to the pandemic, the company benefited substantially from the shift in spending by consumers on products and activities around the home over the first half of 2021 and it managed the business well under volatile, but strong trading conditions, McLennan contends. However, the analyst believes peak trading is unlikely to be sustained. ShowHide Related Items >><<
|
On The Fly
|
Opening Day: Coinbase files to go public »
10:13 02/28/21 02/2810:13 02/28/2110:13
FB
Score Media
Arya Sciences Acquisition Corp IV
Twelve Seas Investment Company II
Austerlitz Acquisition Corporation I
Austerlitz Acquisition Corporation II
Freedom Acquisition I
SilverBox Engaged Merger Corp I
Ibere Pharmaceuticals
Fusion Acquisition Corp. II
African Gold Acquisition
EJF Acquisition
Cartesian Growth
Soaring Eagle Acquisition
FTAC Athena Acquisition
Slam Corp.
Gores Holdings VII
Arctos NorthStar Acquisition
Coinbase
Roblox
Coupang
Caliber Home Loans
Pharming
Cricut
Gold Royalty
Oscar Health
Palantir
Asana
Slack Technologies
Spotify
Alibaba
Coinbase, the biggest… ShowHide Related Items >><<
|
Upgrade
|
Kalbe Farma upgraded to Buy from Neutral at Goldman Sachs »
09:43 02/28/21 02/2809:43 02/28/2109:43
PTKFF
Kalbe Farma
Goldman Sachs analyst… Goldman Sachs analyst June Zhu upgraded Kalbe Farma to Buy from Neutral. The analyst expects earnings growth for Kalbe Farma, Indonesia's biggest pharmaceutical and consumer health manufacturer, to break out from the "anemic levels" seen over the past five years. This new growth phase will be driven by less margin pressure for its prescription pharmaceutical business, oncology/biosimilar drugs' local manufacturing scaling up, rising health awareness, and higher distribution sales growth due to COVID treatment drugs and potentially vaccination given its cold-chain storage and extensive coverage, Zhu adds. ShowHide Related Items >><<
|
Conference/Events
|
FDA PDUFA Date for Athenex Oraxol (oral paclitaxel) is February 28, 2021
04:55 02/28/21 02/2804:55 02/28/2104:55
ATNX
Athenex
ShowHide Related Items >><<
|
Conference/Events
|
FDA PDUFA Date for CorMedix for Defencath is February 28, 2021
04:55 02/28/21 02/2804:55 02/28/2104:55
CRMD
CorMedix
ShowHide Related Items >><<
|
Hot Stocks
|
Johnson & Johnson Covid vaccine granted emergency approval from FDA »
19:15 02/27/21 02/2719:15 02/27/2119:15
JNJ
Johnson & Johnson
The Food and Drug… The Food and Drug Administration issued an emergency use authorization for the third vaccine for the prevention of coronavirus disease The EUA allows Johnson & Johnson's Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older. The FDA has determined that the Janssen COVID-19 Vaccine has met the statutory criteria for issuance of an EUA. The totality of the available data "provides clear evidence that the Janssen COVID-19 Vaccine may be effective in preventing COVID-19," the agency said in a statement. The data also show that the vaccine's known and potential benefits outweigh its known and potential risks, supporting the company's request for the vaccine's use in people 18 years of age and older. The Janssen COVID-19 Vaccine is manufactured using a specific type of virus called adenovirus type 26. The vaccine uses Ad26 to deliver a piece of the DNA, or genetic material, that is used to make the distinctive "spike" protein of the SARS-CoV-2 virus, the FDA said. While adenoviruses are a group of viruses that are relatively common, Ad26, which can cause cold symptoms and pink eye, has been modified for the vaccine so that it cannot replicate in the human body to cause illness, it added. After a person receives this vaccine, the body can temporarily make the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2. ShowHide Related Items >><<
|
Hot Stocks
|
Berkshire Hathaway buys back record $25B of company stock in 2020 »
09:24 02/27/21 02/2709:24 02/27/2109:24
BRK.A
Berkshire Hathaway
Berkshire Hathaway
Warren Buffett's… Warren Buffett's Berkshire Hathaway bought back a record amount of company stock last year. During the fourth quarter, the company bought back about $9B shares for a total 2020 repurchase of $24.7B. Buffett said in his annual shareholder letter that repurchases have continued since year-end and "is likely to further reduce its share count in the future." "That action increased your ownership in all of Berkshire's businesses by 5.2% without requiring you to so much as touch your wallet," the letter reads. ShowHide Related Items >><<
|
Hot Stocks
|
Berkshire Hathaway sees profit rise 23%, says 'never bet against America' »
09:18 02/27/21 02/2709:18 02/27/2109:18
BRK.A
Berkshire Hathaway
Berkshire Hathaway
Warren Buffett Berkshire… Warren Buffett Berkshire Hathaway's fourth quarter profits rose, with its net earnings rising to $38.5B, or $23,015 a Class A share equivalent, up almost 23% from the previous year's profit of $29.2B, or $17,909 a share. Operating earnings, which exclude some investment results, rose to $5B from $4.4B the year before. Buffett also said in his annual shareholder letter to "never bet against America." "In its brief 232 years of existence... there has been no incubator for unleashing human potential like America," he added. "Despite some severe interruptions, our country's economic progress has been breathtaking. Our unwavering conclusion: Never bet against America." Buffett noted that the conglomerate owns the biggest amount of U.S. assets by value than any other company in the country. ShowHide Related Items >><<
|
Periodicals
|
Asos expanding, stock could be 'in fashion' now, Barron's says »
08:55 02/27/21 02/2708:55 02/27/2108:55
ASOMY
Asos
Shares of Asos fell 7.1%… Shares of Asos fell 7.1% in the final three months of 2020 over fears that earnings would take a hit from a slump in demand for its signature partywear collections, Rupert Steiner writes in this week's edition of Barron's. Instead, Asos benefited from being the online destination for shoppers who have been stuck at home during the pandemic, the author notes. Sales at the company jumped 23% over the final four months of 2020, and the stock is up 18% this year. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Ross Stores stock 'a unique bargain' among discount retailers, Barron's says »
08:50 02/27/21 02/2708:50 02/27/2108:50
ROST
Ross Stores
Ross Stores offers… Ross Stores offers shoppers a chance to find overlooked "treasures" among a heap of discards and its stock could offer investors the same opportunity, Teresa Rivas writes in this week's edition of Barron's. The company has had a tough time during the pandemic and its stock has took a bigger beating, the author notes. But the underperformance means that Ross also has the most to gain as more vaccines are given and reopening accelerates, Rivas adds. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Dow ready to 'put doldrums behind," Barron's says »
08:45 02/27/21 02/2708:45 02/27/2108:45
DOW
Dow Inc.
Everything is breaking… Everything is breaking right for chemical company Dow, but market analysts have failed to notice, which means this is one time when investors can get in ahead of Wall Street, Al Root writes in this week's edition of Barron's. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Citigroup stock a Buy, Barron's says »
08:38 02/27/21 02/2708:38 02/27/2108:38
C
Citi
Citigroup is broken-but… Citigroup is broken-but the U.S. banking giant finally might have found the woman to fix it, with Jane Fraser stepping in as CEO on March 1, Carleton English writes in this week's edition of Barron's. Citi has lagged behind the 48% surge in the KBW Bank Index, making it a bank with room to run, the author notes. Fraser has a big job ahead, but it's not a bad time to be taking the helm of America's fourth largest bank by assets, as the U.S. economy continues to recover from last year's COVID-induced recession, English adds. Reference Link ShowHide Related Items >><<
|
Periodicals
|
Utilities offer yield, a way to play green energy, Barron's says »
08:32 02/27/21 02/2708:32 02/27/2108:32
AEP
American Electric
Dominion
Exelon
NextEra Energy
Utility companies offer… Utility companies offer attractive yields and inexpensive valuations, and they are getting better for the environment, Andrew Bary writes in this week edition of Barron's. Investors can play the sector through companies such as American Electric Power (AEP), Dominion Energy (D), Entergy (ETR), Exelon (EXC), and industry leader NextEra Energy (NEE), which has built a large and lucrative renewable-energy business, the author notes. Reference Link ShowHide Related Items >><<
|
On The Fly
|
Charged: Tesla temporarily halts Model 3 line at CA plant »
08:14 02/27/21 02/2708:14 02/27/2108:14
TSLA
Tesla
Intel
Qualcomm
Micron
AMD
Apple
TSMC
Ford
General Motors
Bitcoin
Churchill Capital Corp IV
Foley Trasimene Acquisition Corp. II
Pershing Square Tontine Holdings
FTAC Olympus Acquisition
Reinvent Technology Partners
CIIG Merger
Switchback Energy Acquisition
Forum Merger III
Workhorse Group
Oshkosh
Lordstown Motors
Fisker
Nikola
SolarEdge
Sunrun
SunPower
Sunnova Energy
Welcome to The Fly's… ShowHide Related Items >><<
|
Hot Stocks
|
SSR Mining names Alison White as CFO »
18:56 02/26/21 02/2618:56 02/26/2118:56
SSRM
SSR Mining
Newmont
SSR Mining (SSRM)… SSR Mining (SSRM) announced the appointment of Alison White as Executive Vice President and CFO. Prior to joining SSR Mining, White held various corporate and regional roles at Newmont Mining (NEM) including serving as the Regional CFO for North America. White will join the company at the end of March. ShowHide Related Items >><<
|
Hot Stocks
|
Arista Networks CEO: Our growth is back »
18:25 02/26/21 02/2618:25 02/26/2118:25
ANET
Arista Networks
In an interview on… In an interview on CNBC's Mad Money Jayshree Ullal said Arista is a preferred partner with cloud titans, but it's also looking to diversify. The company is doing everything possible to protect the network and work with best of breed, she added. It has been planning for the worst cases in terms of chip shortages and Ullal is "hoping to recover better" by summer. ShowHide Related Items >><<
|
Hot Stocks
|
Estee Lauder's Haney sells 8,000 class A common shares »
18:04 02/26/21 02/2618:04 02/26/2118:04
EL
Estee Lauder
In a regulatory filing,… In a regulatory filing, Estee Lauder executive VP of Global R&D Carl P. Haney disclosed the sale of 8,000 class A common shares of the company on February 24 at a price of $295.49 per share. ShowHide Related Items >><<
|
Hot Stocks
|
Solaris Oilfield CEO Zartler sells 500,000 common shares »
17:49 02/26/21 02/2617:49 02/26/2117:49
SOI
Solaris Oilfield
In a regulatory filing,… In a regulatory filing, Solaris Oilfield Infrastructure chairman and CEO William A. Zartler disclosed the sale of 500,000 common shares of the company on February 25 at a price of $11 per share. ShowHide Related Items >><<
|
Conference/Events
|
Cowen Internet & restaurants analysts to hold analyst/industry conference call »
17:48 02/26/21 02/2617:48 02/26/2117:48
GRUB
GrubHub
Uber
Internet & New Media… Internet & New Media Analyst Blackledge, Restaurants Analyst Charles and Merger/Event Strategist Glick discuss what is happening and what could happen on an Analyst/Industry conference call to be held on March 5 at 12 pm. ShowHide Related Items >><<
|
Syndicate
|
National Storage files automatic mixed securities shelf
17:47 02/26/21 02/2617:47 02/26/2117:47
NSA
National Storage
ShowHide Related Items >><<
|
Hot Stocks
|
J&J confirms FDA panel recommends COVID-19 vaccine for EUA »
17:45 02/26/21 02/2617:45 02/26/2117:45
JNJ
Johnson & Johnson
Johnson & Johnson… Johnson & Johnson announced that the U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee unanimously voted to recommend Emergency Use Authorization for the company's single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical companies of Johnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including efficacy and safety data from the Phase 3 ENSEMBLE trial. "We are extremely grateful to the VRBPAC members for their extensive review of the data supporting emergency use of Johnson & Johnson's single-shot COVID-19 vaccine candidate," said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer, Johnson & Johnson. "We believe our COVID-19 vaccine candidate has the potential to help change the trajectory of the pandemic and stand ready to make it available to protect the public as soon as possible." The next step in the process is for the FDA to decide whether to grant an EUA for Janssen's COVID-19 vaccine candidate. The recommendation of the FDA Advisory Committee is non-binding, and the final decision on authorization is made by the FDA. Under an EUA, the FDA has the authority to allow unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions during a declared public health emergency. If authorized by the FDA, the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices will then provide a recommendation on the use and roll-out of the Janssen COVID-19 vaccine candidate. ShowHide Related Items >><<
|
Syndicate
|
Invitae files to sell 1.37M shares of common stock for holders
17:43 02/26/21 02/2617:43 02/26/2117:43
NVTA
Invitae
ShowHide Related Items >><<
|